MedPath

Comparison of three-drug and consecutive treatment regimens in the eradication of Helicobacter pylori in patients referred to the gastrointestinal clinic of Imam Khomeini Hospital in Urmia

Not Applicable
Conditions
Comparison of three-drug and consecutive treatment regimens in eradication of Helicobacter pylori in patients referred to the gastrointestinal clinic of Imam Khomeini Hospital in Urmia.
Oesophagitis
Registration Number
IRCT20200907048643N1
Lead Sponsor
Oroumia University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
270
Inclusion Criteria

1- Endoscopic primary infection of Helicobacter pylori
2-Have symptoms of dyspepsia for at least 6 months or more
3- No history of taking any antibiotics during the last month and no history of taking proton and antacid pump inhibitors in the last month

Exclusion Criteria

1- Endoscopic primary infection of Helicobacter pylori
2-Have symptoms of dyspepsia for at least 6 months or more
3- No history of taking any antibiotics during the last month and no history of taking proton and antacid pump inhibitors in the last month

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori treatment. Timepoint: Patients were referred to the clinic 2 weeks, 6 weeks and 10 weeks after starting treatment. Patients were examined for Helicobacter pylori by Stool Ag test. Individuals who were registered for successful negative test treatment for H. pylori eradication. In the second week visit, all side effects including (bad taste, dry mouth, diarrhea, confusion, tongue burn, nausea and vomiting, abdominal pain, constipation and headache) and patient compliance were recorded based on the number of pills remaining and then four weeks PPI only It was taken and then they did not take any PPI and antibiotics for 4 weeks and then it was proved by Stool Ag eradication of Helicobacter pylori infection in each group. Method of measurement: Blood and stool tests.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath